Raleigh, NC - December 19, 2024 - Contego Medical announced today the successful completion of the first commercial cases with the newly FDA-approved Neuroguard IEP® System, an innovative 3-in-1 device combining a high-performance carotid stent, integrated dilation balloon, and integrated filter. The Neuroguard IEP System is clinically proven to meaningfully reduce the risk of procedural and long-term stroke among patients with carotid artery disease.
Contego Medical is a North Carolina-based medical device company that designs devices such as embolic protection and thrombectomy equipment for the healthcare industry.